Biogen CEO Vounatsos nabs $18M payday amid challenges from Tecfidera generics, pandemic

Biogen CEO Vounatsos nabs $18M payday amid challenges from Tecfidera generics, pandemic
esagonowsky
Tue, 04/27/2021 – 10:03